a better future
by transforming precision medicine
In a partnership will molecular diagnostics company Biocartis, ThyroidPrint will be first of its kind globally available diagnostic kit. The cutting edge diagnotic platform Idylla will allow us to provide a sample-to-insight result within the same day. Biocartis will provide manufacturing and distribution channels for ThyroidPrint leveraging its world wide install base of more than 1.800 Idylla platforms.